| abstract |
The novel compounds of formula (I), wherein R1, R2, R2', R2", R3, R4, R5, R5', R5", R5''', R'''', X, Y, U, V and W have the meanings given in patent claim no. 1, are inhibitors of the coagulation factors Xa and VIIa and can be used for treating thromboses, myocardial infarction, arteriosclerosis, inflammations, apoplexy, angina pectoris, restenosis following angioplasty, intermittent claudication, tumours, tumour diseases and/or tumour metastases. |